Effect of exercise training in patients with chronotropic incompetence and heart failure with preserved ejection fraction: Training-HR study protocol

IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
{"title":"Effect of exercise training in patients with chronotropic incompetence and heart failure with preserved ejection fraction: Training-HR study protocol","authors":"","doi":"10.1016/j.cpcardiol.2024.102839","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Chronotropic incompetence (ChI) is linked with diminished exercise capacity in heart failure with preserved ejection fraction (HFpEF). Although exercise training has shown potential for improving functional capacity, the exercise modality associated with greater functional and chronotropic response (ChR) is not well-known. Additionally, how the ChR from different exercise modalities mediates functional improvement remains to be determined. This study aimed to evaluate the effect of three different exercise programs over current guideline recommendations on peak oxygen consumption (peakVO<sub>2</sub>) in patients with ChI HFpEF phenotype.</p></div><div><h3>Methods and results</h3><p>In this randomized clinical trial, 80 stable symptomatic patients with HFpEF and ChI (NYHA class II-III/IV) are randomized (1:1:1:1) to receive: a) a 12-week program of supervised aerobic training (AT), b) AT and low to moderate-intensity strength training, c)AT and moderate to high-intensity strength training, or d) guideline-based physical activity and exercise recommendations. The primary endpoint is 12-week changes in peakVO<sub>2</sub>. The secondary endpoints are 12-week changes in ChR, 12-week changes in quality of life, and how ChR changes mediate changes in peakVO<sub>2</sub>. A mixed-effects model for repeated measures will be used to compare endpoint changes. The mean age is 75.1 ± 7.2 years, and most patients are women (57.5 %) in New York Heart Association functional class II (68.7 %). The mean peakVO<sub>2</sub>, percent of predicted peakVO<sub>2</sub>, and ChR are 11.8 ± 2.6 mL/kg/min, 67.2 ± 14.7 %, and 0.39 ± 0.16, respectively. No significant baseline clinical differences between arms are found.</p></div><div><h3>Conclusions</h3><p>Training-HR will evaluate the effects of different exercise-based therapies on peakVO<sub>2</sub>, ChR, and quality of life in patients with ChI HFpEF phenotype.</p></div><div><h3>Clinical trial registration</h3><p>ClinicalTrials.gov (NCT05649787).</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Problems in Cardiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0146280624004742","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Chronotropic incompetence (ChI) is linked with diminished exercise capacity in heart failure with preserved ejection fraction (HFpEF). Although exercise training has shown potential for improving functional capacity, the exercise modality associated with greater functional and chronotropic response (ChR) is not well-known. Additionally, how the ChR from different exercise modalities mediates functional improvement remains to be determined. This study aimed to evaluate the effect of three different exercise programs over current guideline recommendations on peak oxygen consumption (peakVO2) in patients with ChI HFpEF phenotype.

Methods and results

In this randomized clinical trial, 80 stable symptomatic patients with HFpEF and ChI (NYHA class II-III/IV) are randomized (1:1:1:1) to receive: a) a 12-week program of supervised aerobic training (AT), b) AT and low to moderate-intensity strength training, c)AT and moderate to high-intensity strength training, or d) guideline-based physical activity and exercise recommendations. The primary endpoint is 12-week changes in peakVO2. The secondary endpoints are 12-week changes in ChR, 12-week changes in quality of life, and how ChR changes mediate changes in peakVO2. A mixed-effects model for repeated measures will be used to compare endpoint changes. The mean age is 75.1 ± 7.2 years, and most patients are women (57.5 %) in New York Heart Association functional class II (68.7 %). The mean peakVO2, percent of predicted peakVO2, and ChR are 11.8 ± 2.6 mL/kg/min, 67.2 ± 14.7 %, and 0.39 ± 0.16, respectively. No significant baseline clinical differences between arms are found.

Conclusions

Training-HR will evaluate the effects of different exercise-based therapies on peakVO2, ChR, and quality of life in patients with ChI HFpEF phenotype.

Clinical trial registration

ClinicalTrials.gov (NCT05649787).

慢动作不全和射血分数保留型心力衰竭患者运动训练的效果:训练-心率研究方案》。
背景:射血分数保留型心力衰竭(HFpEF)患者的运动能力减弱与嗜铬细胞功能不全(ChI)有关。虽然运动训练已显示出提高功能能力的潜力,但与更大的功能和促时差反应(ChR)相关的运动方式并不为人所知。此外,不同运动模式的ChR如何介导功能改善仍有待确定。本研究旨在评估三种不同的运动项目与现行指南建议相比,对 ChI HFpEF 表型患者峰值耗氧量(peakVO2)的影响:在这项随机临床试验中,80 名症状稳定的 HFpEF 和 ChI(NYHA II-III/IV 级)患者被随机分配(1:1:1:1:1)接受:a)为期 12 周的有氧训练(AT)项目;b)有氧训练和中低强度力量训练;c)有氧训练和中高强度力量训练;或 d)基于指南的体力活动和运动建议。主要终点是峰值血氧量在 12 周内的变化。次要终点是 12 周 ChR 的变化、12 周生活质量的变化以及 ChR 的变化如何介导峰值 VO2 的变化。将采用重复测量的混合效应模型来比较终点变化。平均年龄为 75.1±7.2 岁,大多数患者为女性(57.5%),纽约心脏协会功能分级为 II 级(68.7%)。平均峰值 VO2、预测峰值 VO2 百分比和 ChR 分别为 11.8±2.6 mL/kg/min、67.2±14.7% 和 0.39±0.16。两组之间没有发现明显的基线临床差异:训练-HR将评估不同运动疗法对ChI HFpEF表型患者的峰值VO2、ChR和生活质量的影响:临床试验注册:ClinicalTrials.gov (NCT05649787)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Problems in Cardiology
Current Problems in Cardiology 医学-心血管系统
CiteScore
4.80
自引率
2.40%
发文量
392
审稿时长
6 days
期刊介绍: Under the editorial leadership of noted cardiologist Dr. Hector O. Ventura, Current Problems in Cardiology provides focused, comprehensive coverage of important clinical topics in cardiology. Each monthly issues, addresses a selected clinical problem or condition, including pathophysiology, invasive and noninvasive diagnosis, drug therapy, surgical management, and rehabilitation; or explores the clinical applications of a diagnostic modality or a particular category of drugs. Critical commentary from the distinguished editorial board accompanies each monograph, providing readers with additional insights. An extensive bibliography in each issue saves hours of library research.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信